ArticleFrontiers in immunology2022

A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.

Hui-Hui Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.